David L. Hallal
Net Worth
Last updated:
What is David L. Hallal net worth?
The estimated net worth of Mr. David L. Hallal is at least $13,501,516 as of 19 Oct 2022. He owns shares worth $1,630,482 as insider, has earned $8,927,974 from insider trading and has received compensation worth at least $2,943,060 in AlloVir, Inc..
What is the salary of David L. Hallal?
Mr. David L. Hallal salary is $981,020 per year as Executive Chairman in AlloVir, Inc..
How old is David L. Hallal?
Mr. David L. Hallal is 59 years old, born in 1966.
What stocks does David L. Hallal currently own?
As insider, Mr. David L. Hallal owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| AlloVir, Inc. (ALVR) | Executive Chairman | 138,153 | $11.8 | $1,630,482 |
What does AlloVir, Inc. do?
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts.
David L. Hallal insider trading
AlloVir, Inc.
Mr. David L. Hallal has made 8 insider trades in 2022, according to the Form 4 filled with the SEC. Most recently he sold 600,000 units of ALVR stock worth $5,070,000 on 19 Oct 2022.
The largest trade he's ever made was exercising 600,000 units of ALVR stock on 19 Oct 2022. As of 19 Oct 2022 he still owns at least 138,153 units of ALVR stock.
AlloVir key executives
AlloVir, Inc. executives and other stock owners filed with the SEC:
- Dr. Diana M. Brainard M.D. (54) Chief Executive Officer & Director
- Dr. Ercem Atillasoy M.D. (61) Chief Regulatory & Safety Officer
- Mr. David L. Hallal (59) Executive Chairman
- Mr. Vikas Sinha C.A., CPA, M.B.A. (62) Pres, Chief Financial Officer & Director